MIVT Purchase Of Vascore Would Provide Access To Stent Market
This article was originally published in The Gray Sheet
Biocompatible coating-developer MIV Therapeutics (MIVT) is making a second attempt to enter the lucrative stent market via its proposed acquisition of Chinese stent manufacturer Vascore Medical
You may also be interested in...
Biocompatible coating developer MIV Therapeutics (MIVT) says it is in talks with drug manufacturers to discover a compound exhibiting "paclitaxel-like" traits for integration with the firm's emerging stent line
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.